Replies to post #14527 on Regen BioPharma Inc (RGBP)

[kfox]

All reasonable conclusions save one. IF the Hema safety study once submitted ( for a 28 day trial could be submitted already) is accepted and full FDA approval AND Orphan Drug Status are given. Then this goes up by 500 to 1000 pct in a day. There is no chasing, it's gone. Both approvals are very close IMO.

[cvinvestor]

Sid,

The comments centered around "roadblocks".

Sure there has been progress in the personnel front. But so far that hasn't helped in stopping the share price from tanking. And it doesn't guarantee FDA approval of the IND.

Personnel hiring never guarantees a stock price in any direction other than a flash in the pan PR effect. Personnel never guarantees FDA approval - we are fully agreed on that and have never made a claim otherwise. But both hiring good people and competent scientists with increased IP go a long way in the long run towards the success of both.

Maybe you can explain to me with all the changes, why the stock keeps going down? 15 might be the bottom but I'd rather chase with good news than be a bag holder. And if the science truly does work, this will be a very special stock.

"Why the stock keeps going down" is relative to time frames. From the RGBP charts I watch, the stock "keeps going up and down". Up with positive developments and speculation to slowly falling back down in between good news. Why?
I can only speculate:
1. Part is common sense of OTC stocks where MMs make money on creating a price market that moves - in both directions.
2. Part is penny stock DT action where there are various levels of advertising pump and dump actions to make a quick buck and pennies can be manipulated while large corp are more resistent to such action.
3. RGBP is currently R&D company only, so doesn't have benefit of large investment firms yet maintaining and protecting share value. If RGBP goes down 20% in a day on $10,000 worth of shares sold, who worries? Only those trying to flip for a buck. $10,000 in shares traded is no major bailout of investors and will disappear on news of success.

I fully agree and have said so multiple times that the success of RGBP hinges on concrete positive news of IND approval - they have to get the first one on paper, regardless of which pipeline product it is. Once they get an IND approved, a lot will change I believe going into the future. Success builds on success. Until then, the price will drift, fall, bounce, sky rocket or move sideways - on any combo of factors listed above, including general overall market trends as well.

What you should not ignore when considering whether to invest or not, is that when comparing 2015 to previous years, RGBP now has 2 full time employed scientists vs. none prior, several more patents and the acquisition of other IP in 2015, 6 new name recognizable scientists as advisors, each specializing in a field directly related to pipeline products, an experienced company in IND submittals doing GLP safety testing for HemaX, money in the bank vs overdraft balance in 2014 and the fact that the Ichims have presented both orally and with abstracts at several internationally attended scientific conferences.

Timing as to when you or anyone should invest is not for me to say. That's up to you, your style of investing and risk factors. There are no guarantees in this whatsoever.

GLTA